Outcomes of treatment efficacy | |
Aggression* | |
Agitation | |
Depression | |
Apathy | |
Anxiety | |
Night-time behaviors | |
Motor disturbances | |
Irritability | |
Disinhibition | |
Psychosis (delusions and hallucinations) | |
Appetite and eating abnormalities | |
Caregiver well-being | |
Overall quality of life (both patient and caregiver) | |
Improvement in function | |
Admission to skilled nursing facility | |
Outcomes of treatment safety | |
Fractures* | |
Falls | |
Stroke | |
Mortality | |
Prolonged QTc interval | |
Myocardial infarction | |
Pneumonia | |
Deterioration in cognition | |
Hyperprolactinemia | |
Weight gain | |
Somnolence | |
Hypotension | |
Edema | |
Cytopenia | |
Extrapyramidal side effects (e.g., tardive dyskinesia) | |
Hospitalization | |
Admission to intensive care unit (ICU) |